Our working hypothesis was that ACh would enhance these biological responses in PCa cells through the down-regulation of Glo1 and subsequent accumulation of MG-H1, which would activate downstream pro-tumorigenic pathways, including the up-regulation of OPN. The gene discussed is GLO1; the disease is posterior cortical atrophy.